2003•Journal of Neural TransmissionRequires access

Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia

Doron Gothelf, Alan S. Apter, JUDITH REIDMAN, Ayelet Brand‐Gothelf, Yuval H. Bloch, Gilad Gal, L. Kikinzon, Samuel Tyano, R. Weizman, GIDI RATZONI

Open publisher page 63 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 63 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Olanzapine, Haloperidol, Risperidone, Extrapyramidal symptoms, Psychology, Schizophrenia (object-oriented programming), Dopamine antagonist, Positive and Negative Syndrome Scale

Back to paper search Browse research topics Original source

Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia — Research Paper | ScholarLens